Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic promotions

This article was originally published in The Gray Sheet

Executive Summary

Bob Guezuraga is named senior-VP and president of the company's Cardiac Surgery business effective Sept. 1, Medtronic reports Aug. 13. Guezuraga currently serves as VP and general manager of Medtronic's Physio-Control division. Jodi Harpstead is adding global marketing for the firm's Cardiac Rhythm Management division to her current responsibilities as head of U.S. sales and marketing for that business. Taking over as VP-U.S. sales and marketing for the Cardiac Surgery unit is 23-year Medtronic veteran Dan Pelak. The newly created position of VP-corporate marketing will be held by Chuck Brynelsen, who currently serves as VP-U.S. CRM marketing

You may also be interested in...



Novartis Targets Ten Indications For Cosentyx

The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.

Zydus Cadila Strides Ahead With NASH Filing In India

Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.

 

Interview: Double Delight For ImmuPharma's Dimitriou

It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.

UsernamePublicRestriction

Register

MT012180

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel